You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Dermatology

European Academy of Allergy and Clinical Immunology (EAACI) 2023 | Hamburg

Presentation highlights from the ADVENT symposium at the EAACI 2023 congress in Hamburg, Germany.

Stephan Weidinger
Peter  Arkwright
Oscar Palomares
MD, PhD
Stephan Weidinger +7 more
Past event
9June2023
Location
Congress Center Hamburg CCH
Hamburg Germany

Learning objectives

  • Examine the multidimensional disease burden in children with AD and their families/caregivers, and the impact of type 2 comorbidities
  • Learn about the impact of targeting type 2 inflammation in children with AD, from the normalization of the skin barrier to the improvement of bone mineralization markers
  • Provide an overview of the treatment landscape in children with AD, and examine updates on clinical trials of dupilumab

Description

  • Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?
    • In this ADVENT symposium at the 2023 EAACI congress, “Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?”, Stephan Weidinger, MD, PhD (University Hospital Schleswig-Holstein), Peter Arkwright, MD, PhD (University of Manchester), and Oscar Palomares, PhD (University of Madrid), discussed the multidimensional disease burden of atopic dermatitis in children, the pathophysiology of the disease driven by type 2 inflammation, and the current treatment landscape for pediatric patients with atopic dermatitis.
Location
Congress Center Hamburg CCH
Hamburg Germany

Speakers